Please ensure Javascript is enabled for purposes of website accessibility

Release Details

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

September 1, 2022

WALTHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in September:

  • Citi 17th Annual BioPharma Conference: Fireside chat on Wednesday, September 7, 2022 at 1:00 p.m. ET.

  • Wells Fargo Healthcare Conference: Fireside chat on Thursday, September 8, 2022 at 1:55 p.m. ET.

  • Baird 2022 Global Healthcare Conference: Presentation on Wednesday, September 14, 2022 at 3:10 p.m. ET.

  • BofA Global Research Global Healthcare Conference 2022: Presentation on Friday, September 16, 2022 at 3:05 p.m. BST / 10:05 a.m. ET.

The conference events will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 30 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya